MAR
72
-2
CCL
68
-2
ZBH
50
3
AKAM
35
-18
FMC
30
-3
CLX
44
-2
CL
47
-3
NVDA
61
-2
PFE
23
-5
NEE
54
8
LEG
55
2
GOOGL
37
-5
DHI
25
-2
O
35
2
SE
80
-8
ECL
45
-2
QCOM
57
-9
GT
45
-2
VRSK
77
4
LOW
53
-3
MAR
72
-2
CCL
68
-2
ZBH
50
3
AKAM
35
-18
FMC
30
-3
CLX
44
-2
CL
47
-3
NVDA
61
-2
PFE
23
-5
NEE
54
8
LEG
55
2
GOOGL
37
-5
DHI
25
-2
O
35
2
SE
80
-8
ECL
45
-2
QCOM
57
-9
GT
45
-2
VRSK
77
4
LOW
53
-3
Financhill
Sell
41

ALNY Quote, Financials, Valuation and Earnings

Last price:
$251.26
Seasonality move :
25.91%
Day range:
$250.35 - $260.00
52-week range:
$144.73 - $304.39
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
13.75x
P/B ratio:
283.68x
Volume:
656.4K
Avg. volume:
1.1M
1-year change:
65.92%
Market cap:
$32.7B
Revenue:
$2.2B
EPS (TTM):
-$2.09

Alnylam Pharmaceuticals SEC Filings

Company Filed Form Type Description
ALNY
Alnylam Pharmaceuticals
 05/02/2024 10-Q 10-Q filing on 05/02/2024 View Form
ALNY
Alnylam Pharmaceuticals
 11/02/2023 10-Q 10-Q filing on 11/02/2023 View Form
ALNY
Alnylam Pharmaceuticals
 08/03/2023 10-Q 10-Q filing on 08/03/2023 View Form
ALNY
Alnylam Pharmaceuticals
 05/04/2023 10-Q 10-Q filing on 05/04/2023 View Form
ALNY
Alnylam Pharmaceuticals
 10/27/2022 10-Q 10-Q filing on 10/27/2022 View Form
ALNY
Alnylam Pharmaceuticals
 07/28/2022 10-Q 10-Q filing on 07/28/2022 View Form
ALNY
Alnylam Pharmaceuticals
 04/28/2022 10-Q 10-Q filing on 04/28/2022 View Form
ALNY
Alnylam Pharmaceuticals
 10/28/2021 10-Q 10-Q filing on 10/28/2021 View Form
ALNY
Alnylam Pharmaceuticals
 08/03/2021 10-Q 10-Q filing on 08/03/2021 View Form
ALNY
Alnylam Pharmaceuticals
 04/29/2021 10-Q 10-Q filing on 04/29/2021 View Form
ALNY
Alnylam Pharmaceuticals
 02/11/2021 10-K 10-K filing on 02/11/2021 View Form
ALNY
Alnylam Pharmaceuticals
 11/05/2020 10-Q 10-Q filing on 11/05/2020 View Form
ALNY
Alnylam Pharmaceuticals
 08/06/2020 10-Q 10-Q filing on 08/06/2020 View Form
ALNY
Alnylam Pharmaceuticals
 05/06/2020 10-Q 10-Q filing on 05/06/2020 View Form
ALNY
Alnylam Pharmaceuticals
 02/13/2020 10-K 10-K filing on 02/13/2020 View Form
ALNY
Alnylam Pharmaceuticals
 10/31/2019 10-Q 10-Q filing on 10/31/2019 View Form
ALNY
Alnylam Pharmaceuticals
 08/06/2019 10-Q 10-Q filing on 08/06/2019 View Form
ALNY
Alnylam Pharmaceuticals
 05/02/2019 10-Q 10-Q filing on 05/02/2019 View Form
ALNY
Alnylam Pharmaceuticals
 02/14/2019 10-K 10-K filing on 02/14/2019 View Form
ALNY
Alnylam Pharmaceuticals
 11/07/2018 10-Q 10-Q filing on 11/07/2018 View Form
ALNY
Alnylam Pharmaceuticals
 08/02/2018 10-Q 10-Q filing on 08/02/2018 View Form
ALNY
Alnylam Pharmaceuticals
 05/04/2018 10-Q 10-Q filing on 05/04/2018 View Form
ALNY
Alnylam Pharmaceuticals
 02/15/2018 10-K 10-K filing on 02/15/2018 View Form
ALNY
Alnylam Pharmaceuticals
 11/07/2017 10-Q 10-Q filing on 11/07/2017 View Form
ALNY
Alnylam Pharmaceuticals
 08/09/2017 10-Q 10-Q filing on 08/09/2017 View Form
ALNY
Alnylam Pharmaceuticals
 05/05/2017 10-Q 10-Q filing on 05/05/2017 View Form
ALNY
Alnylam Pharmaceuticals
 02/15/2017 10-K 10-K filing on 02/15/2017 View Form
ALNY
Alnylam Pharmaceuticals
 11/03/2016 10-Q 10-Q filing on 11/03/2016 View Form
ALNY
Alnylam Pharmaceuticals
 08/04/2016 10-Q 10-Q filing on 08/04/2016 View Form
ALNY
Alnylam Pharmaceuticals
 05/04/2016 10-Q 10-Q filing on 05/04/2016 View Form
ALNY
Alnylam Pharmaceuticals
 02/12/2016 10-K 10-K filing on 02/12/2016 View Form
ALNY
Alnylam Pharmaceuticals
 11/09/2015 10-Q 10-Q filing on 11/09/2015 View Form
ALNY
Alnylam Pharmaceuticals
 08/07/2015 10-Q 10-Q filing on 08/07/2015 View Form

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Free Training Webinar

Related Companies

Get ALNY Stock Alert

Signup to receive the latest stock alerts

Financial Ratios

ALNY
Sector
P/E ratio
--
23.51x
PEG ratio
--
0.00x
P/B ratio
283.68x
1.65x
Price / LTM sales
13.75x
1.60x

Growth Metrics

ALNY
Sector
Revenue growth
20.2%
4.92%
Earnings growth
--
7.49%
Revenue (5-year growth)
59.22%
8.25%
Earnings forecast
$0.46
-$0.20

Profitability

ALNY
Sector
Profitability FY 2024
$1.9B
$53.7M
Return on invested capital
-26.39%
-14.69%
Return on assets
-6.58%
-11.84%
Return on equity
--
-17.27%

Earnings Date

Last Earnings Date
May
1
Next Earnings Date
Aug
1
Estimated Next Earnings Date
Jul
31

Balance Sheet

ALNY
Sector
Total cash
$2.6B
$40.3M
Short term investments
$1.7B
$34.6M
Total assets
$4.2B
$119.9M
Long term debt
$1B
$9M

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Free Training Webinar

Popular

3 Recession-Proof ETFs to Invest in Now
3 Recession-Proof ETFs to Invest in Now

The U.S. gross domestic product (GDP) contracted 0.3% during the…

Read article
Is Butterfly Network the Best Small-Cap Stock?
Is Butterfly Network the Best Small-Cap Stock?

Brought to public trading by an SPAC merger in early…

Read article
Is Spotify a Millionaire-Maker Stock?
Is Spotify a Millionaire-Maker Stock?

Spotify (NYSE:SPOT) may seem like an expensive proposition trading closer…

Read article

Stock Ideas

Buy
68
Is MSFT Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 37x

Buy or Sell?
Sell
39
Is AAPL Stock a Buy?

Market Cap: $3T
P/E Ratio: 33x

Buy or Sell?
Buy
61
Is NVDA Stock a Buy?

Market Cap: $2.8T
P/E Ratio: 40x

Buy or Sell?

Alerts

Buy
60
RGC alert for May 10

Regencell Bioscience Holdings [RGC] is up 79.25% over the past day.

Buy or Sell?
Buy
97
NGVC alert for May 10

Natural Grocers by Vitamin Cottage [NGVC] is up 30.26% over the past day.

Buy or Sell?
Sell
38
ONTO alert for May 10

Onto Innovation [ONTO] is down 30.17% over the past day.

Buy or Sell?
Master Safe Stock Market Strategies
Get Paid To Own Stocks. Insure Your Stocks During Downtrends. Master "The Vacation Trade".

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock

Watchlist

Stock Score

Seasonality

Analyze

Covered Calls

Valuation

Smart Money

Education

E-Book

Newsletters

Companies

Dividends

Traders Library

Big Movers

Stock Ideas